Satsuma Pharmaceuticals Inc. buy BiotechBee
Start price
08.09.22
/
50%
€6.30
Target price
31.12.24
€8.00
Performance (%)
-88.33%
End price
14.12.22
€0.74
Summary
This prediction ended on 14.12.22 with a price of €0.74. The BUY prediction by BiotechBee for Satsuma Pharmaceuticals Inc. performed very badly with a performance of -88.33%. BiotechBee has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Satsuma Pharmaceuticals Inc. | - | - | - | - |
| iShares Core DAX® | 0,79 % | 1,97 % | 13,39 % | 49,83 % |
| iShares Nasdaq 100 | 4,23 % | 4,34 % | 39,72 % | 89,76 % |
| iShares Nikkei 225® | 3,29 % | 6,99 % | 49,89 % | 64,38 % |
| iShares S&P 500 | 2,50 % | 2,76 % | 30,23 % | 64,25 % |
According to BiotechBee what are the pros and cons of Satsuma Pharmaceuticals Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year